There are currently more than 150 different COVID-19 vaccines under development. Of these, more than 50 have reached human trials, and several have been approved for emergency or full use on six continents. In the US, two vaccines—one from the biotechnology company, Moderna and the other from drug giant Pfizer—have been granted an Emergency Use Authorization (EUA) from the FDA. To read the full story.
Recent Posts
- Researchers Investigate How to Integrate Behavioral Health into Primary Care.
- Scientists map the half-billion connections that allow mice to see.
- New COVID-19 Drug Shows Greater Promise Against Resistant Viral Strains.
- How a new library is set to transform this underserved N.J. community
- Poll Finds Majority of New Jerseyans Give Negative Ratings to State and National Economy.
Categories
- News (2,509)
- Publication (1)